Mar 16, 2022 7:00am EDT Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
Mar 08, 2022 9:53am EST Todos Medical Appoints Greg Meiselbach as Vice President of Government Affairs
Jan 27, 2022 8:23am EST Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients
Jan 24, 2022 8:34am EST Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Jan 19, 2022 8:00am EST Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge®, Presented by Todos Medical’s Tollovid®
Jan 18, 2022 10:52am EST Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
Jan 12, 2022 9:56am EST Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
Jan 10, 2022 2:06pm EST Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
